Search
for
Sort by
Research 181–210 of 1000+
- Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
- p53 Is a Direct Transcriptional Repressor of Keratin 17: Lessons from a Rat Model of Radiation Dermatitis
- <i>Trichophyton tonsurans</i>‐induced kerion celsi with decreased defensin expression and paradoxically increased interleukin‐17A production
- Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
- IL-17a induces age-related olfactory dysfunction by impairing regeneration and promoting respiratory metaplasia in mice
- Association of Serum IL-17A and IL-23 Levels With Alopecia Areata: A Cross-Sectional Comparative Study
- Assessment of Interleukin-17A and Interleukin-2 Serum Levels in Patients with Alopecia Areata
- Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata
- DEVELOPING AND VALIDATING AN HPLC METHOD TO QUANTIFY SIMULTANEOUSLY DUTASTERIDE AND THEIR RELATED MOLECULES (DUTASTERIDE ACID, 2,5 BIS- (TRI FLUORO METHYL)-ANILINE AND DUTASTERIDE 17 α-EPIMER) IN CAPSULES
- Cortexolone 17a-propionate: A new antiandrogen acting on hair dermal papilla cells for the treatment of androgenic alopecia
- Cortexolone 17a-propionate: Preclinical profile of a new topical, skin selective, steroidal antiandrogen
- Regularities of Change Concentrations of Interleukin-17A, Interleukin-2 and Interleukin-10 in the Blood of People with Alopecia Areata before and after Treatment with Platelet-Rich Plasma
- Psoriasis patients demonstrate HLA-Cw*06:02 allele dosage-dependent T cell proliferation when treated with hair follicle-derived keratin 17 protein
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Localization and Regulation of Expression of the FAR-17A Gene in the Hamster Flank Organs
- Keratins 6, 16, and 17 in Health and Disease: A Summary of Recent Findings
- Non-classical Congenital Adrenal Hyperplasia Presenting With Severe Androgenic Alopecia: A Case Report
- Progress on clinical applications of chlormadinone acetate
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity
- Evaluation of New Pregnane Derivatives as 5.ALPHA.-Reductase Inhibitor.
- Emerging Therapies for Acne Vulgaris
- Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa
- Altered expression of intracellular Toll-like receptors in peripheral blood mononuclear cells from patients with alopecia areata
- Successful treatment of refractory folliculitis decalvans with secukinumab
- Hair follicles modulate skin barrier function
- Alopecia Areata After Initiation of Secukinumab Therapy for Plaque Psoriasis
- Effects of dihydrotestosterone on osteoblast activity in curdlan-administered SKG mice and osteoprogenitor cells in patients with ankylosing spondylitis
- Granulomatous pigmented purpuric dermatosis containing Propionibacterium acnes
- Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris